Event Alerts
Date Lead Company Event Type Approval Change Approval Likelihood 09/02/10 Takeda (4502:JP) Contrave for Obesity Subscribers Only Subscribers Only     Subscribers Only 09/01/10 Cardiome (CRME) Kynapid for Dysrhythmia (Arrhythmia) Subscribers Only Subscribers Only     Subscribers Only 09/01/10 Genzyme (GENZ) Mipomersen Sodium (SC) for Dyslipidemia/Hypercholesterolemia Subscribers Only Subscribers Only     Subscribers Only 08/31/10 Bayer (BAY:GR) Xarelto for Venous Thromboembolism (VTE) Subscribers Only Subscribers Only     Subscribers Only 08/31/10 Bristol-Myers (BMY) Apixaban for Stroke Prevention in Atrial Fibrillation (SPAF) Subscribers Only Subscribers Only     Subscribers Only More...
Expected Date Range Lead Company Drug Expected Catalyst Now - 09/03/10        Subscribers Only      Subscribers Only       Regulatory - Meeting with FDA       09/03/10        Subscribers Only      Subscribers Only       Trial Data - Updated Results       09/03/10        Subscribers Only      Subscribers Only       Company - Earnings Announcement       09/04/10        Subscribers Only      Subscribers Only       Trial Data - Updated Results       09/06/10        Subscribers Only      Subscribers Only       Regulatory - PDUFA/Approval Decision (US)       More...
08/19/10   Nature News Briefing - Pharma's Next Blockbuster - HCV 08/13/10   Nature News - Boost for drugs against hepatitis C 08/03/10   Nature Reviews Drug Discovery - Impact of PDUFA on Regulatory Decision-Making 07/22/10   BioMedTracker Announces New Features   More...